Arch. Dis. Child

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in ADC Online
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slack, M H
Right arrow Articles by Miller, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slack, M H
Right arrow Articles by Miller, E
Archives of Disease in Childhood Fetal and Neonatal Edition 2004;89:F57
© 2004 Archives of Disease in Childhood Fetal and Neonatal Edition


ORIGINAL ARTICLE

Acellular pertussis vaccine given by accelerated schedule: response of preterm infants

M H Slack1, D Schapira2, R J Thwaites1, C Schapira2, J Bamber3, M Burrage4, J Southern5, N Andrews5, E Miller5

1 Department of Paediatrics, St Mary’s Hospital, Portsmouth, UK
2 Department of Paediatrics, Royal Hampshire County Hospital, Winchester, UK
3 Department of Neonatal Medicine, Princess Anne Hospital, Southampton, UK
4 Centre for Applied Microbiology and Research, Salisbury, Wiltshire, UK
5 Immunisation Division, Communicable Disease Surveillance Centre, Public Health Laboratory Service, London, UK

Correspondence to:
Correspondence to:
Dr Slack
Department of Paediatrics, St Mary’s Hospital, Portsmouth P03 6AD, UK; marts{at}doctors.org.uk

Objective: To describe the immune response of preterm infants to a diphtheria/tetanus/three component acellular pertussis (DTaP) vaccine, under an accelerated schedule, and the effects of steroids on this response. To compare responses with those of term infants.

Design: Prospective observational study.

Setting: Five Wessex neonatal units; Hertfordshire immunisation clinics.

Patients: Infants born at < 32 weeks; term controls.

Interventions: DTaP-Haemophilus influenzae type b vaccine given at 2, 3, and 4 months. Blood taken to assess antibody responses to vaccines.

Main outcome measures: IgG geometric mean concentrations (GMC) to vaccines.

Results: A total of 130 preterm (mean gestational age 29.1 weeks) and 54 term infants were recruited. After the third immunisation, preterm infants had similar GMCs to controls to diphtheria, tetanus, filamentous haemagglutinin (FHA), and pertactin (PRN), but a significantly lower GMC to pertussis toxin (PT). Responses to tetanus and PRN increased with age at the third immunisation, and those to tetanus, FHA, PRN, and PT increased with gestational age at birth. Response to tetanus correlated negatively with the number of doses of antenatal steroids received. There was no association between responses and postnatal steroids.

Conclusion: When immunised with a combined acellular pertussis- H influenzae type b vaccine under an accelerated schedule, IgG GMC of preterm infants to PT was reduced. GMCs to tetanus, FHA, PRN, and PT increased with gestational age at birth, and GMCs to tetanus and PRN increased with age at the third immunisation. There is, however, no benefit in delaying immunisation. Anti-tetanus IgG decreased with increasing number of doses of antenatal steroids. There was no effect for postnatal steroids.


Keywords: premature; vaccines; acellular pertussis; steroids

Abbreviations: aP, acellular pertussis; DTP, diphtheria/tetanus/pertussis; FHA, filamentous haemagglutinin; GMC, geometric mean concentration; Hib, Haemophilus influenzae b; MCC, meningococcal serogroup C; PRN, pertactin; PT, pertussis toxin; wP, whole cell pertussis




This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
J Bonhoeffer, C-A Siegrist, and P T Heath
Immunisation of premature infants
Arch. Dis. Child., November 1, 2006; 91(11): 929 - 935.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
M H Slack, S Cade, D Schapira, R J Thwaites, A Crowley-Luke, J Southern, R Borrow, and E Miller
DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation
Arch. Dis. Child., April 1, 2005; 90(4): 338 - 341.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. Berrington and A. Fenton
Immunization Responses in Preterm Infants Who Receive Postnatal Steroid Treatment
Pediatrics, October 1, 2004; 114(4): 1127 - 1128.
[Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
P Clarke, M J Robinson, and P J Powell
DTP immunisation of steroid treated preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2004; 89(5): F468 - F468.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
ARCH DIS CHILD FETAL NEONATAL ED ED PRACTICE
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health